Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:39 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 2,849 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard care alone Clear all

Conditions: Preterm Infant Health, Premature Babies
Interventions: Human Milk Concentration Device, Standard of Care Fortified Feeding; Device · Other
Lead sponsor: Mother's Milk is Best; Industry
Eligibility: 32 Weeks to 35 Weeks
Enrollment: 310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Rectal Adenocarcinoma
Interventions: Chemoradiation, short course radiation therapy, mFOLFOX6, CAPOX, fluoropyrimidine +/- oxaliplatin; Other · Radiation · Drug
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years to 99 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Hearing Loss
Interventions: Clinically Streamlined and Structured Aural Rehabilitation (CSSAR); Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 55 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Heart Failure, Methamphetamine Use Disorder
Interventions: MUD Management (contingency management +/- adjunctive MUD pharmacotherapy), HF GDMT management; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Cerebral Palsy
Interventions: oral analgesic, intravenous analgesic per pump; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 3 Years to 17 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Lung Neoplasms
Interventions: Blood draw; Other
Lead sponsor: Shadia Jalal; Other
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Twin Twin Transfusion Syndrome
Interventions: Selective Laser Photocoagulation of Communicating Vessels; Device
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Cachexia, Neoplasms
Interventions: standard care, nutritional supplements and advice, home-based self-assisted exercise program, Ibuprofen; Other · Dietary Supplement · Behavioral + 1 more
Lead sponsor: Norwegian University of Science and Technology; Other
Eligibility: 18 Years and older
Enrollment: 221 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Infertility
Interventions: Hera Score; Device
Lead sponsor: Alife Health; Industry
Eligibility: 21 Years to 43 Years · Female only
Enrollment: 444 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 7
States / cities: Menlo Park, California • San Ramon, California • Margate, Florida + 4 more

Conditions: Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer (Adenocarcinoma)
Interventions: aglatimagene besadenovec + valacyclovir, External Beam Radiation Therapy (EBRT); Biological · Radiation
Lead sponsor: Candel Therapeutics, Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 7
States / cities: Peoria, Arizona • Lakewood, Colorado • Littleton, Colorado + 4 more

Conditions: Hypoxemia
Interventions: Capnography; Diagnostic Test
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 263 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Diseases of Liver, Colon Carcinoma, Colorectal Carcinoma, Liver Metastases
Interventions: Computed Tomography Scan - 50% Dose Reduction, Computed Tomography Scan - 70% Dose Reduction, Deep Learning Image Reconstruction (DLIR); Diagnostic Test
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Periodontitis Chronic Generalized Severe, Periodontitis Chronic Generalized Moderate
Interventions: leukocyte platelet rich fibrin (L-PRF), Scaling and Root Planing; Biological · Procedure
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Infant Development, Language Development, Prematurity, Stress
Interventions: Music, Music and parent voice, Standard Care; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 24 Weeks to 30 Weeks
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 2
States / cities: New Haven, Connecticut • Boston, Massachusetts

Conditions: Cardiac Rehabilitation, Health Coaching, Physical Activity
Interventions: Targeted Health Coaching Group, Standard Care Group; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 60 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pressure Ulcers Stage III, Pressure Ulcer, Stage IV, Pressure Ulcer
Interventions: MicroMatrix® and Cytal™ Wound Matrix 2-Layer, MicroMatrix® and Cytal™ Wound Matrix 2-Layer plus NPWT, Negative Pressure Wound Therapy; Device
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 21 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Diabetic Foot Ulcer, Venous Leg Ulcer
Interventions: PelloGraft, SanoGraft; Other
Lead sponsor: Surgenex; Industry
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Vista, California • Tulsa, Oklahoma

Conditions: Body Weight Changes, Overweight
Interventions: Group weight loss program, Group weight loss program plus use of the Senseware Armband, Use of the senseware armband alone program; Behavioral · Other · Device
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Enrollment: 197 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Chronic Sinusitis
Interventions: PROPEL Mini Sinus Implant., Sinus Surgery alone, Propel Nova Sinus Implant; Device · Procedure
Lead sponsor: Intersect ENT; Industry
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 10
States / cities: Sacramento, California • Torrance, California • Norwalk, Connecticut + 7 more

Conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Myelodysplastic Syndromes, Acute Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Chronic Myeloid Leukemia
Interventions: Orca-T; Biological
Lead sponsor: Orca Biosystems, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 21
States / cities: Duarte, California • Los Angeles, California • Sacramento, California + 16 more

Conditions: Brain Cancer, Brain Metastases, Melanoma, Lung Cancer, Breast Cancer, HER2-positive Breast Cancer, Colorectal Cancer, Gastrointestinal Cancer, SRS, SRT, Whole Brain Radiation, Stereotactic Radiation, AGuIX, Nanoparticle, Cystic, Brain Tumor
Interventions: Stereotactic Radiation, AGuIX gadolinium-based nanoparticles, Placebo; Radiation · Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Rehabilitation, ACL Reconstruction
Interventions: HOME, TNMT; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 13 Years to 30 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 4
States / cities: Flowery Branch, Georgia • Minneapolis, Minnesota • Rochester, Minnesota + 1 more

Conditions: Alcohol Dependence, Alcohol Abuse
Interventions: Motivational Interviewing, Spirit-Only Motivational Interviewing, Self-Change; Behavioral · Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Diabetic Foot Ulcers
Interventions: Dual Layer Amniotic Membrane (DLAM). Artacent®; Biological
Lead sponsor: SerenaGroup, Inc.; Network
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 15
States / cities: Phoenix, Arizona • Los Angeles, California • Pembroke Pines, Florida + 12 more

Search by objective public record fields.

Human Milk Concentrating Device to Optimize Mother's Own Milk

Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

Benefit of a Clinically Streamlined and Structured Aural Rehabilitation (CSSAR) Program in Adults

Methamphetamine Use Disorder Support in Heart Failure Pilot Study

Managing Post-operative Pain in Children With Cerebral Palsy Using a Pain Pump

Circulating Tumor Cells (CTC) in Lung Cancer

Selective Laser Photocoagulation of Communicating Vessels in Twin-Twin Transfusion Syndrome

Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy

Evaluation of the Alife Hera System as an Adjunctive Tool for the Prioritization of Embryos Deemed Suitable for Transfer

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Does Capnography Prevent Hypoxemia During Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound?

Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques

Scaling and Root Planning With Localized Delivery of Autogenous Growth Factors- Platelet Rich Fibrin (PRF)

The Impact of Music Medicine on Preterm Brain Development and Behavior

Targeted Health Coaching to Improve Physical Activity Post-Structured Cardiac Rehabilitation

Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytal™ to Standard of Care in Stage 3 or 4 Pressure Injuries

Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC

Lifestyle Education for Activity and Nutrition for a Leaner You

Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implant in Frontal Sinus

Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Neuromuscular Intervention Targeted to Mechanisms of ACL Load in Female Athletes

Project Motion, A Study of Motivational Interviewing to Reduce Heavy or Problematic Drinking

Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)